FTI Consulting
FCN
$160.99
-3.57%
FTI Consulting, Inc. is a global business advisory firm providing professional services across five segments: corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications, operating within the Industrials sector's consulting services industry. The company is a distinct player as a leading independent advisor, often engaged for complex, mission-critical situations like mergers, disputes, and investigations, serving a diverse client base across numerous sectors. The current investor narrative is focused on the stock's perceived undervaluation despite strong financial performance, as highlighted by recent news of a significant institutional investment betting on upside potential, juxtaposed against the stock's recent price weakness and its sensitivity to broader economic cycles affecting its core advisory services.…
FCN
FTI Consulting
$160.99
Related headlines
Investment Opinion: Should I buy FCN Today?
Rating & Thesis: Hold. FCN presents a classic 'value trap' dilemma—fundamentally sound but technically broken—making it unsuitable for new money until the price stabilizes or fundamentals re-assert dominance. The single analyst EPS estimate of $12.16 and forward P/E of 15.71x suggest underlying value, but the lack of a consensus price target and recent downgrade to 'Hold' underscore the uncertainty.
Supporting Evidence: The valuation argument is mixed: the forward P/E of 15.7x is reasonable for a firm with a 15.62% ROE, but the high PEG ratio of 4.41 and premium Price-to-Sales of 1.47x are concerns. Positively, revenue grew 10.71% YoY in Q4, the balance sheet is strong (D/E 0.34), and free cash flow generation is healthy at $166.6 million TTM. However, these strengths are offset by the stock's severe -12.72% one-month relative strength and sequential margin compression in the latest quarter.
Risks & Conditions: The two biggest risks are continued cyclical pressure on the Corporate Finance segment and further multiple compression if growth decelerates. This Hold rating would upgrade to a Buy if the stock finds durable support above its 52-week low and the forward P/E compresses further towards 14x while revenue growth stabilizes above 8%. It would downgrade to a Sell if revenue growth turns negative or the stock breaks decisively below the $149 support level. Based on the current data, FCN appears fairly valued to slightly overvalued when considering its high PEG ratio and weak momentum, despite its attractive standalone P/E.
Sign up to view all
FCN 12-Month Price Forecast
The AI assessment is neutral with medium confidence. FCN is a fundamentally sound company caught in a negative momentum spiral, creating a stalemate between value and sentiment. The attractive forward P/E and strong cash flow are compelling, but they are currently overpowered by technical weakness, cyclical risks, and sparse analyst support. The stance would upgrade to bullish on a confirmed technical reversal (e.g., a sustained move above $185) coupled with evidence of accelerating revenue growth. It would turn bearish if the stock breaks below $149, confirming the downtrend and invalidating the value proposition.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on FTI Consulting's 12-month outlook, with a consensus price target around $209.29 and implied upside of +30.0% versus the current price.
Average Target
$209.29
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$129 - $209
Analyst target range
Analyst coverage for FTI Consulting appears limited, with data indicating only one analyst providing estimates, which suggests insufficient broad institutional coverage to form a robust consensus. The single analyst provides an estimated EPS average of $12.16 and revenue estimate of $4.54 billion for the forward period, but a consensus price target and Buy/Hold/Sell distribution are not available in the provided dataset, preventing calculation of implied upside or downside. The implication of minimal analyst coverage is significant; it typically denotes a mid-cap stock ($5.5B market cap) that may fly under the radar of larger research firms, leading to potentially higher volatility and less efficient price discovery. The available institutional ratings show sporadic activity, with the last action being a reaffirmation of 'Hold' by Truist Securities in October 2025, following a downgrade from 'Buy' in April 2025; this pattern indicates a neutral-to-cautious stance from the few covering firms, but the lack of a target range limits insight into the assumptions behind bullish or bearish scenarios.
Bulls vs Bears: FCN Investment Factors
The evidence presents a balanced but tense investment case. The bull argument is anchored in strong fundamentals: a pristine balance sheet, robust cash flow, and a valuation that appears attractive relative to the company's own history, bolstered by a recent large institutional vote of confidence. The bear case is driven by severe technical deterioration, significant market underperformance, and concerns over cyclical revenue concentration and earnings volatility. Currently, the bearish technical and sentiment signals hold stronger immediate evidence, as the stock's price action contradicts its solid financials. The single most important tension is whether the market's recent punishment of the stock (due to cyclical fears and poor momentum) has created an attractive entry point for a fundamentally sound company, or if it foreshadows a fundamental slowdown that the financials have yet to fully reflect.
Bullish
- Strong Balance Sheet & Cash Flow: FTI Consulting maintains a robust financial position with a low debt-to-equity ratio of 0.34 and a solid current ratio of 1.56, indicating minimal financial risk. The company generates substantial free cash flow of $166.6 million (TTM), providing ample internal funding for growth and share repurchases.
- Undervalued vs. Own History: The stock's trailing P/E of 20.52x is below its recent historical highs of 33.84x (end of 2024) and 24.66x (Q4 2025), suggesting relative value. The forward P/E of 15.71x, based on an estimated EPS of $12.16, implies a significant discount to trailing earnings and expectations for growth.
- Institutional Bet on Upside: Recent news highlights a major institutional investor making a $183 million bet on FCN, signaling strong confidence in its upside potential despite recent stock weakness. This action points to a belief that the stock is undervalued given its record earnings performance.
- Consistent Profitability & ROE: The company is consistently profitable with a Q4 2025 net margin of 5.5% and an operating margin of 9.43%. A return on equity of 15.62% demonstrates efficient use of shareholder capital, supported by stable gross margins around 32%.
Bearish
- Severe Recent Underperformance: The stock has significantly underperformed the market, down 12.72% vs. the S&P 500 over the past month and 23.83% over the past year. This sharp relative weakness, including a recent -14.82% max drawdown, indicates waning momentum and negative investor sentiment.
- Limited Analyst Coverage & Downgrade: Analyst coverage is sparse, with only one firm providing estimates, leading to potential price inefficiency and volatility. The last institutional rating action was a downgrade from 'Buy' to 'Hold' by Truist Securities in April 2025, reflecting a cautious stance.
- Cyclical Revenue Concentration: The majority of revenue comes from the Corporate Finance segment, which is highly sensitive to M&A activity and economic cycles. This concentration creates vulnerability to a downturn in transactional advisory work, directly impacting top-line growth.
- High PEG Ratio Suggests Overvaluation: A PEG ratio of 4.41, calculated using the trailing P/E of 20.52x and the 5.21% 1-year price change as a proxy for growth, is extremely high. This indicates the stock's valuation may not be justified by its recent growth trajectory, posing a risk of multiple compression.
FCN Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 5.21% one-year price change, but is currently experiencing a significant pullback from recent highs. With a current price of $173.82, it is trading at approximately 65% of its 52-week range ($149.31 to $189.30), positioning it closer to the midpoint but having retreated meaningfully from the high, suggesting a loss of momentum and potential consolidation after a strong run. Recent momentum has turned sharply negative, with the stock down 2.74% over the past month and 0.49% over the past three months, which diverges from the positive six-month change of 5.34%; this short-term weakness, particularly the -12.72% relative strength versus the S&P 500 over one month, indicates significant underperformance and a potential corrective phase within the longer-term uptrend. Key technical support is at the 52-week low of $149.31, while immediate resistance is at the recent high near $189.30. A decisive break below the $149 support would signal a potential trend reversal and open the door to further declines, whereas a reclaim of the $180-$185 zone would suggest the recent pullback was a healthy consolidation. The stock's volatility, implied by its significant underperformance relative to the market (SPY up 9.98% over one month vs. FCN's -2.74%), suggests it carries higher idiosyncratic risk, which is critical for risk management despite the absence of a specific beta figure in the provided data.
Beta
0.00
0.00x market volatility
Max Drawdown
-14.8%
Largest decline past year
52-Week Range
$149-$189
Price range past year
Annual Return
-2.6%
Cumulative gain past year
| Period | FCN Return | S&P 500 |
|---|---|---|
| 1m | -12.5% | +11.4% |
| 3m | -9.3% | +8.3% |
| 6m | -1.5% | +9.4% |
| 1y | -2.6% | +31.3% |
| ytd | -5.5% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FCN Fundamental Analysis
Revenue growth remains positive but shows signs of sequential deceleration; the most recent quarterly revenue (Q4 2025) was $990.7 million, representing a 10.71% year-over-year increase, yet this follows quarters with potentially higher growth rates, as seen in the upward trajectory from Q1 2025's $898.3 million. The Corporate Finance segment, at $423.2 million in the latest period, is the primary revenue driver, indicating the company's core strength in transactional advisory, which is cyclical and tied to M&A activity. This growth trend, while solid, suggests the investment case is more about steady execution and margin expansion rather than hyper-growth. The company is profitable, with Q4 2025 net income of $54.5 million and a net margin of 5.5%. Gross margin for the quarter was 31.05%, which is consistent with the trailing gross margin of 32.13%, indicating stable pricing power and cost management. Profitability has been robust through the year, with operating income of $93.4 million in Q4 and an operating margin of 9.43%, demonstrating the firm's ability to convert revenue into earnings despite its people-intensive business model. Balance sheet health is strong, with a conservative debt-to-equity ratio of 0.34 and a solid current ratio of 1.56, indicating good liquidity. The company generates substantial cash flow, with trailing twelve-month free cash flow of $166.6 million, providing ample internal funding for growth initiatives and share repurchases. Return on equity of 15.62% is respectable and reflects efficient use of shareholder capital, supported by the healthy free cash flow generation which yields financial flexibility and low financial risk.
Quarterly Revenue
$990746000.0B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.31%
Latest Quarter
Free Cash Flow
$166577000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FCN Overvalued?
Given the company's consistent profitability with positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 20.52x, while the forward PE is notably lower at 15.71x, indicating the market expects earnings growth; the significant gap suggests analysts project a meaningful increase in earnings per share in the coming year, aligning with the forward EPS estimate of $12.16. Compared to industry averages, FTI Consulting trades at a premium on a sales basis, with a Price-to-Sales ratio of 1.47x, though direct industry average PS data is not provided for comparison. The EV/EBITDA multiple of 13.32x offers another lens, but without a sector benchmark, the assessment relies on the PE comparison; the forward PE of 15.7x appears reasonable for a firm with a mid-single-digit revenue growth profile and double-digit ROE, suggesting the premium, if any, is likely justified by its market position and cash flow stability. Historically, the stock's current trailing PE of 20.52x sits below its own recent historical range observed in the data, such as the 24.66x at the end of Q4 2025 and the 33.84x at the end of 2024. This positioning near the lower end of its recent historical valuation band suggests the market may be pricing in less optimistic expectations or that the stock offers relative value compared to its own trading history, potentially presenting an opportunity if fundamentals remain intact.
PE
20.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 15x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: FTI Consulting's primary financial risk is earnings volatility, as evidenced by the sequential drop in Q4 2025 net income to $54.5 million from $82.8 million in Q3, despite revenue growth. The company's heavy reliance on the Corporate Finance segment (its largest revenue driver) creates concentration risk, making top-line growth highly dependent on the health of the M&A and capital markets cycle. While the balance sheet is strong with a D/E of 0.34, the high PEG ratio of 4.41 suggests the market is pricing in growth that may not materialize, risking valuation compression if earnings disappoint.
Market & Competitive Risks: The stock trades at a forward P/E of 15.71x, which appears reasonable, but its severe underperformance versus the S&P 500 (-12.72% over one month) indicates it is suffering from significant sector or stock-specific de-rating. As a consulting firm, it faces intense competition for talent and mandates, and its services are economically sensitive—a slowdown in corporate spending or deal-making would directly pressure revenues. The lack of broad analyst coverage (only one firm) exacerbates these risks by contributing to lower liquidity and potentially exaggerated price moves on news.
Worst-Case Scenario: The most damaging scenario would be a pronounced economic downturn coinciding with a freeze in M&A activity, severely impacting the core Corporate Finance segment. This could trigger a double whammy of revenue declines and multiple compression, as the current P/E reverts towards its 52-week low valuation implied by a price of $149.31. From the current price of $173.82, a drop to the 52-week low represents a realistic downside of approximately -14%. If sentiment deteriorates further amid missed earnings, a decline towards the $140s (a -20% drawdown) is plausible, mirroring the stock's recent volatile swings.
FAQ
The key risks are, in order of severity: 1) Cyclical and Concentration Risk: Over-reliance on the economically sensitive Corporate Finance segment for revenue. 2) Valuation Compression Risk: The high PEG ratio of 4.41 makes the stock vulnerable if growth slows. 3) Sentiment and Liquidity Risk: Severe recent underperformance (-12.72% in one month) and limited analyst coverage can lead to exaggerated downturns. 4) Earnings Volatility Risk: Sequential net income dropped from $82.8M in Q3 to $54.5M in Q4 2025, indicating inconsistent profitability.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $165 and $185, as steady execution maintains its current forward P/E. The Bull Case (25% probability) targets $189 to $205, driven by an M&A rebound and a valuation re-rating. The Bear Case (15% probability) risks a fall to the $149 to $160 range if economic conditions worsen. The most likely outcome is the Base Case, assuming the company meets its $12.16 EPS estimate but fails to catalyze significant multiple expansion amid ongoing cyclical concerns.
FCN's valuation sends mixed signals, leaning towards fair value with a risk of being overvalued on a growth-adjusted basis. Its trailing P/E of 20.52x is below its own historical highs, suggesting relative undervaluation. However, the extremely high PEG ratio of 4.41 indicates the market price is not justified by its recent growth rate. Compared to its fundamentals—15.62% ROE and 10.71% revenue growth—the forward P/E of 15.71x seems fair. The market is paying a fair price for steady earnings but a premium for hoped-for growth that has yet to materialize consistently.
FCN is a contentious buy at its current price. On one hand, its forward P/E of 15.71x and strong balance sheet suggest it is not expensive for a firm with its profitability. The recent $183 million institutional investment also signals insider confidence. However, the severe recent underperformance (-12.72% vs. market in one month), high PEG ratio of 4.41, and cyclical revenue risks make it a speculative buy. It could be a good buy for a patient value investor seeking a misunderstood quality name, but it is not suitable for risk-averse or short-term investors given its current weak momentum.
FCN is more suitable for a medium-to-long-term investment horizon (2+ years) rather than short-term trading. Its value proposition is based on fundamental metrics (P/E, ROE, FCF) that may take time to be recognized by the market, especially given its current negative momentum. The stock's volatility, evidenced by a -14.82% max drawdown and significant underperformance, makes it a poor short-term trading vehicle. Long-term investors can look through cyclical swings to capture the firm's durable competitive position and cash generation, but they must be prepared for interim volatility.